Nonetheless, despite the activation of these potentially pro-tumorigenic pathways, tumors in Zbp1−/− mice were significantly smaller, suggesting that these responses may be inadequate to counteract the overall inhibitory effect of ZBP1 deficiency on tumor progression (Fig. 2E). The gene discussed is ZBP1; the disease is neoplasm.